Menu

Recent Interviews

Jerre Foo, Corporate Development Executive, Silkroad Nickel

Jerre Foo
Corporate Development Executive | Silkroad Nickel
50 Armenian Street #03-04, 179938 Singapore (SGP)

enquiries@silkroadnickel.com

+65 6327 8971

Silkroad Nickel: 'The course is set for dynamic profit growth.'


Dr. Thomas Gutschlag, CEO, Deutsche Rohstoff AG

Dr. Thomas Gutschlag
CEO | Deutsche Rohstoff AG
Q7, 24, 68161 Mannheim (D)

info@rohstoff.de

+49 621 490 817 0

Interview Deutsche Rohstoff AG: "We can imagine additional investments in the field of electromobility."


Steve Cope, President, CEO and Director, Silver Viper

Steve Cope
President, CEO and Director | Silver Viper
1055 W Hastings St Suite 1130, V6E 2E9 Vancouver (CAN)

info@silverviperminerals.com

+1-604-687-8566

Interview with Silver Viper: Future price drivers and takeover fantasy


01. October 2020 | 13:35 CET

Aurelius, Lukoil, SolGold: What do the jacks-of-all-trades on the stock exchange offer?

  • Investments
Photo credits: pixabay.com

Those who can do a little bit of everything can go far in the professional world. Currently, the discussion about "neo-generalists" is dominating the career pages. In a world of change it is advantageous to be knowledgeable in many varied sectors, but experts criticize half-knowledge and half-baked proposals from the professional jack-of-all-trades. There are companies on the stock exchange that offer a colorful bouquet of activities. Often, the market does not initially assess this adequately. One example is the investment company, Aurelius. Whenever opportunities for acquisitions arise in promising sectors, Aurelius snaps at them. The result is a varied bouquet of investments. Aurelius itself supports the companies and plans to sell them again after successful restructuring. At present, the company has a full exit pipeline, but the market environment seems a little unfavorable given the crisis. However, diversity can pay off here - after all, not all industries are equally affected.

time to read: 3 minutes by Nico Popp


 

Author

Nico Popp

At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

About the author


Aurelius discourages short-term investors

The crisis threatens fundamentally healthy companies. For an investment company like Aurelius, this can open up great opportunities, but the company is not doing so well on the stock market. Despite a price-earnings ratio of around 5, the share price is not getting off the ground. Some shareholders are afraid that the crisis will delay distributions. Many investors who want to see money quickly have taken their leave of the share.

On a one-year horizon, Aurelius lost a whopping 63%, even though the company recently quintupled its earnings (EBITDA) to € 187.3 million in its nine-month figures. Nevertheless, the share price did not get off the ground. It seems that many investors are still shying away from the large number of companies in the Aurelius portfolio and see the business model as a burden rather than an opportunity.

Lukoil is no longer a pearl of value

The market has paid little attention to the Lukoil share for years. However, this is primarily due to the origin of the oil company: Russian shares have been in a difficult position since the beginning of the sanctions and are little appreciated by investors. Lukoil covers the entire value chain along with oil production and even has petrol stations on offer.

The Corona crisis and the lockdown in China hit Lukoil early on and caused the company to make losses in the first half of the year. Sales alone have fallen by a third. The reason was also the cutbacks in funding for Opec+. In the meantime, the price-earnings ratio of the Lukoil share is back in the double digits at around 15, after having been well below 5 for years.

On a one-year horizon, the Lukoil share lost more than thirty percent and is no longer considered undervalued due to the decline in profits. Nevertheless, the company has a lot to offer: Lukoil is sitting on large oil reserves and continues to hold on to its dividend. The company is currently paying out more than 10% of its share price to investors. This is a solid starting position for long-term investors who believe in a relaxation of the political situation and a comeback of oil prices.

SolGold dances at many weddings - focus in Ecuador

Investors of SolGold do not have to hope and wait - after all, SolGold focuses on copper and gold. The British-Australian exploration company was one of the first companies to secure extensive raw material rights in Ecuador. The company is active in Australia and the Solomon Islands and has various subsidiaries accordingly.

At the heart of the company is the Alpala project in Ecuador, in which the company has an 85% stake and for which a preliminary feasibility study is currently underway. The Company recently released details of the study and confirmed that there will be no changes to the previously published resource estimate. There have only been delays in certain areas, which the company now hopes to catch up on as soon as possible.

The fantasy around SolGold is quite different: Besides Alpala, the company has thirteen other projects in Ecuador. In the long term, this should create synergy effects. For this reason, too, the company pushes all projects forward equally and thus ensures a continuous news flow. All projects are located in the middle of the promising Andes belt.

Promising prospects for copper and gold

Although the SolGold share has already gained almost 20% on a one-year horizon, the market is cautious about the company's prospects. Unlike many comparable companies, SolGold has significantly fewer projects that are neglected. This should justify higher ratings.

Companies such as Newcrest Mining, BHP Billiton, or Franco Nevada have also recognised that SolGold's approach can be promising and have invested in SolGold projects. As with Aurelius or Lukoil, it can be worthwhile for investors to take a closer look at all the projects and examine their potential. In contrast to other industries, the current timing seems to be favorable for companies involved in copper and gold mining.


Author

Nico Popp

At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

About the author



Conflict of interest & risk note

In accordance with §34b WpHG we would like to point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH may hold long or short positions in the aforementioned companies and that there may therefore be a conflict of interest. Apaton Finance GmbH may have a paid contractual relationship with the company, which is reported on in the context of the Apaton Finance GmbH Internet offer as well as in the social media, on partner sites or in e-mail messages. Further details can be found in our Conflict of Interest & Risk Disclosure.


Related comments:

20. April 2021 | 09:45 CET | by Stefan Feulner

Varta, Sierra Growth, CureVac - Clear signals!

  • Investments

Sometimes, for various reasons, it takes longer before the positive developments of a Company are absorbed by the market and thus provide for price gains. It is currently similar to the precious metal gold, which is still in the consolidation phase. The facts such as national debt, inflation fears and the ultra-loose monetary policy of the central banks speak another clear language.

Read

20. April 2021 | 07:10 CET | by Carsten Mainitz

BioNTech, SunMirror, Steinhoff - Great News!

  • Investments

Shortly before the finish line, the going gets tough again. Many athletes and those who have to really "bite" in the last few meters before a deadline are probably familiar with this feeling. Everyday life in the Corona pandemic is also becoming more exhausting. Now, with BioNTech's announcement that it will double weekly vaccine dose deliveries to around 5.1 million units from the end of May, there may be a breakthrough in achieving herd immunity in Germany in the next few months. It is not only good news for the Company's shareholders but everyone. Below we present two other companies whose shareholders should be very pleased. Let us surprise you!

Read

15. April 2021 | 07:15 CET | by Stefan Feulner

Alibaba, The Place Holdings, CureVac - Great opportunities lie here!

  • Investments

The German vaccination disaster is going into the next round. After the AstraZeneca vaccine's back and forth and the question of whether only younger people, older people or no one should be vaccinated with the vaccine, the American vaccine manufacturer Johnson & Johnson is now experiencing delivery stoppages. The return to "normality" once again seems to be a long way off. Another question to ask yourself. What will future life in the new normal look like in the hard-pressed inner cities?

Read